The Surgical Clips segmentation by application delineates four principal use‑cases that collectively drive market revenue. General surgery accounts for the largest share, roughly 45 % of total sales, as clips are routinely employed for tissue approximation and vessel ligation across procedures such as appendectomies and hernia repairs. Cardiovascular applications, representing about 30 % of the market, involve specialized clips for coronary artery bypass grafting and minimally invasive valve interventions, where precision and biocompatibility are critical. Gynecology contributes an estimated 15 % share, with clips used in hysterectomy, tubal ligation, and ovarian cystectomy to secure vascular structures while minimizing thermal damage. Finally, Urology comprises the remaining 10 %, primarily in nephrectomy and prostatectomy where clip deployment facilitates rapid hemostasis in confined anatomical spaces. Each segment’s proportion reflects procedural volume, regulatory pathways, and the clinical preference for clip‑based hemostasis versus suturing, thereby shaping the overall Surgical Clips market size.